Efficacy and safety of induction therapy with rabbit antithymocyte globulins in liver transplantation for hepatitis C
- 1 November 2004
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 36 (9) , 2757-2761
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipientsLiver Transplantation, 2004
- The natural history and outcome of liver transplantation in hepatitis C virus-infected recipientsLiver Transplantation, 2003
- The role of immunosuppression in recurrence of hepatitis CLiver Transplantation, 2003
- Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy1Transplantation, 2003
- Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipientsHepatology, 2002
- Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipientsLiver Transplantation, 2002
- Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: Results from a double-blind randomized placebo-controlled trialLiver Transplantation, 2002
- Anti-Interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantationLiver Transplantation, 2001
- Steroid-free liver transplantation using rabbit antithymocyte globulin induction: Results of a prospective randomized trialLiver Transplantation, 2001
- Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.Journal of Clinical Investigation, 1996